Investigating how astrocytes contribute to blood vessel problems in Alzheimer's disease
STAT3 activation in astrocytes as a driver of neurovascular dysfunction in Alzheimer's disease and related dementias
This study is looking at how a special brain cell called an astrocyte and a protein called STAT3 might affect blood vessel health in people with Alzheimer's disease, which could help us understand more about how these issues develop and progress.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project ID | NIH-10785691 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of astrocytes, a type of brain cell, in the neurovascular dysfunction associated with Alzheimer's disease and related dementias. The researchers will explore how the activation of a specific protein, STAT3, in astrocytes affects the health of blood vessels and the blood-brain barrier. By examining postmortem brain tissue and using human cell models, they aim to uncover the complex interactions between reactive astrocytes and the brain's vascular system. This could lead to new insights into how neurovascular issues contribute to the progression of Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related dementias.
Not a fit: Patients with non-neurodegenerative conditions or those without cognitive impairment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that improve vascular health in patients with Alzheimer's disease.
How similar studies have performed: While some studies have explored astrocyte behavior in other contexts, this specific investigation into STAT3 activation in Alzheimer's disease is relatively novel.
Where this research is happening
Nashville, UNITED STATES
- Vanderbilt University — Nashville, United States (Active)
Researchers
- Principal investigator: Lippmann, Ethan — Vanderbilt University
- Study coordinator: Lippmann, Ethan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.